News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,008 Results
Type
Article (88166)
Company Profile (825)
Press Release (783997)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18431)
Job Trends (17439)
News (398112)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (40)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (373)
Approvals (18629)
Artificial intelligence (676)
Autoimmune disease (189)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (172)
Brain cancer (69)
Breast cancer (693)
Cancer (5304)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77356)
Collaboration (1938)
Company closure (5)
Compensation (1222)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6626)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7315)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (257)
Earnings (100695)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135755)
Executive appointments (1068)
FDA (21783)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1631)
Gene editing (230)
Generative AI (71)
Gene therapy (711)
GLP-1 (1164)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23032)
Metabolic disorders (1470)
mRNA (201)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3235)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (717)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67131)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23904)
Phase 2 (33567)
Phase 3 (25285)
Pipeline (5958)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (270)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (997)
Real estate (7444)
Recruiting (81)
Regulatory (29318)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (7)
Last 7 days (933)
Last 30 days (2883)
Last 365 days (32641)
2026 (5321)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51676)
Australia (9081)
California (12137)
Canada (3459)
China (1223)
Colorado (512)
Connecticut (526)
Delaware (361)
Europe (118890)
Florida (1802)
Georgia (393)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (573)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (47)
Louisiana (31)
Maine (84)
Maryland (1509)
Massachusetts (8890)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3254)
New Mexico (33)
New York (3199)
North Carolina (1673)
North Dakota (10)
Northern California (5867)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2416)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4699)
Tennessee (185)
Texas (1908)
United States (43646)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,008 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ontario becomes the first province to publicly reimburse the first targeted oral therapy for adults with Grade 2 IDH-mutant glioma.
March 1, 2026
·
4 min read
Press Releases
Pendopharm announces the commercialization of Buccolam® in Canada
March 1, 2026
·
2 min read
Press Releases
Lilly’s Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
March 1, 2026
·
16 min read
Press Releases
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit 2026
March 1, 2026
·
1 min read
Press Releases
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
March 1, 2026
·
14 min read
Press Releases
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 1, 2026
·
15 min read
Press Releases
Nkarta to Participate in March 2026 Investor Conferences
March 1, 2026
·
1 min read
Press Releases
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
February 27, 2026
·
5 min read
Press Releases
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
February 27, 2026
·
5 min read
Press Releases
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
February 27, 2026
·
6 min read
1 of 87,301
Next
